USP39 and cancer: A recent study highlighted the potential role of Ubiquitin Specific Peptidase 39 (USP39) as a valuable immune-related biomarker with both diagnostic and prognostic utility across multiple cancer types, especially PDAC, emphasizing its promise as a therapeutic target for cancer immunotherapy [21].